Trial intelligence / Profile preview

Atorvastatin for brain health in elderly (STAREE-Mind)

NCT05586750Phase 4Active, not recruiting

Sponsor
Monash University
Start
Sep 2019
Primary completion
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in Dementia, No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity., sponsored by Monash University. Started Sep 2019; status: active, not recruiting.

02

Drugs

atorvastatin
03

Conditions

DementiaNo canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.

Beyond the preview

Go deeper on NCT05586750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05586750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call